Filter
281
Text search:
molecular
markers
Featured
Recommendations
43
New Publications
55
Language
Document type
No document type
119
Guidelines
68
Studies & Reports
53
Manuals
18
Fact sheets
9
Strategic & Response Plan
7
Training Material
5
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
32
Global
13
Latin America and the Carribbean
9
Kenya
7
Africa
6
South Africa
5
Brazil
3
Sierra Leone
2
Philippines
2
Pakistan
2
Tanzania
2
West and Central Africa
2
South–East Asia Region
2
Asia
2
Venezuela
2
Vietnam
2
North America
2
Liberia
1
Nigeria
1
Congo, Democratic Republic of
1
USA
1
Ethiopia
1
Cameroon
1
Ghana
1
Zimbabwe
1
Nepal
1
Afghanistan
1
Zambia
1
Syria
1
Cambodia
1
Thailand
1
China
1
Malawi
1
Benin
1
Peru
1
Myanmar / Burma
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Laos
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
69
Clinical Guidelines
51
Public Health
24
Pharmacy & Technologies
15
Women & Child Health
4
Key Resources
4
Capacity Building
3
Toolboxes
COVID-19
34
TB
28
Malaria
24
Mental Health
21
HIV
18
NTDs
17
AMR
14
NCDs
14
Rapid Response
8
Ebola & Marburg
5
Refugee
4
Pharmacy
4
2.0 Rapid Response
4
Planetary Health
3
Disability
2
Cholera
2
Specific Hazards
2
Polio
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and
...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and
...
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | This consensus document on Management of Gallbladder cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecu
...
Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers
summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and mo
...
Prepared as an outcome of ICMR Subcommittee on Tongue Cancer | This Consensus Document on Management of Tongue Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecul
...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca
...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular
...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and
...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and
...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecul
...
Full document available: https://www.icmr.nic.in/sites/default/files/guidelines/Gastric%20Cancer%20Final%20pdf%20for%20farrow_0.pdf | Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Gastri
...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m
...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different
...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o
...
This publication provides recommendations for the management of critically ill adult patients with COVID-19 being treated in intensive care units (ICUs) in the Americas. These clinical practice guidelines provide evidence-informed recommendations for identifying
...
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i
...
